Devices › Device types
FDA product code QCA · class 3 · Unknown
Intracranial coil-assist stent: medical device reports filed with FDA
832 reports carry this product code, 2019–2026; 3 brands with a page.
- 832
- reports with this product code
- 0% of all MAUDE reports
- 351
- reports, 12 months to August 2026
- 293 in the 12 months before
- 67.5%
- classified as malfunction
- 62.3% across all reports
- 1.2%
- classified as death, as reported
- 0.9% across all reports
Product code QCA is FDA's classification for "Intracranial coil-assist stent" (unknown panel), a class 3 device. 832 medical device reports carry this product code, 0% of the MAUDE database, from July 2019 to August 2026.
351 reports arrived in the 12 months to August 2026, up 20% from 293 in the 12 months before. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases. The event types recorded are malfunction (67.5%), injury (31.3%) and death (1.2%). 3 brand names with a page on this site carry this code; the brands table is ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."
Brands with this product code
| Brand | Reports | Latest 12 months | Classified as death | Classified as malfunction |
|---|---|---|---|---|
| Neuroform Atlas 3 0mm X 21mm No Tip - Ce | 150 | 93 | 0% | 87.9% |
| Neuroform Atlas 3 0mm X 15mm No Tip - Ce | 80 | 41 | 1.9% | 90% |
| Fred 27 | 1 | 13 | 5.3% | 10.6% |
Ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."
Manufacturers named
| Manufacturer (as written on reports) | Reports | Share |
|---|---|---|
| Stryker Neurovascular Cork | 489 | 58.8% |
| Microvention | 336 | 40.4% |
Reports by month, five years
FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases.
Event type and report source
Event type
Who filed
Grey bar: all 26,136,888 MAUDE reports.
Device problems coded
| Device problem (FDA code) | Reports | Share |
|---|---|---|
| Premature activation | 328 | 39.4% |
| Fracturea broken bone | 80 | 9.6% |
| Retraction problem | 61 | 7.3% |
| Activation failure | 57 | 6.9% |
| Difficult or delayed activation | 51 | 6.1% |
| Activation problem | 25 | 3% |
| Migrationthe device moved from where it was placed | 20 | 2.4% |
| Breakthe device broke | 15 | 1.8% |
| Detachment of device or device componentpart of the device came off | 8 | 1% |
| Difficult to fold, unfold or collapse | 8 | 1% |
| Difficult to open or close | 7 | 0.8% |
| Device stenosis | 6 | 0.7% |
| Difficult to insertthe device was hard to insert | 6 | 0.7% |
| Entrapment of device | 6 | 0.7% |
| Material separation | 5 | 0.6% |
| Premature separation | 5 | 0.6% |
| Component missing | 4 | 0.5% |
| Difficult to advance | 4 | 0.5% |
| Difficult to removethe device was hard to remove | 4 | 0.5% |
| Structural problem | 4 | 0.5% |
Questions about intracranial coil-assist stent reports
What is product code QCA?
FDA's classification code for "Intracranial coil-assist stent", class 3, reviewed by the unknown panel. Every device report carries the product code of the device involved.
How many reports carry this code?
832 reports through August 2026, 351 of them in the latest 12 months.
Which brands appear most often?
Neuroform Atlas 3 0mm X 21mm No Tip - Ce (150), Neuroform Atlas 3 0mm X 15mm No Tip - Ce (80) and Fred 27 (1). Widely used products collect more reports because more people use them.
Can the brands table be used to rank the devices?
No. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." Brands differ in how many are in use, how long they have been sold and how reports are collected.
Where this comes from. Counts are built from the openFDA Device Adverse Event (MAUDE) bulk export released 28 Sep 2026, which holds reports FDA received through 31 Aug 2026. Brand, generic and manufacturer names are as written on the reports; product code names come from FDA's device classification. No report narrative, lot number, patient detail or reporter identity is published. See the methodology and sources; FDA's record is authoritative, and corrections are handled within five working days.
Drug data (FAERS) through 30 Jun 2026; device data (MAUDE) through 31 Aug 2026. Not medical advice.